Press Releases
Alize Pharma launches the first Phase I clinical trial for AZP-531, its unacylated ghrelin analog, in type 2 diabetes
Alize Pharma, a company specialized in the development of drugs for the treatment of metabolic diseases and rare diseases, announces today the launch of...
Press Releases
Impax Laboratories Launches Authorized Generic TRILIPIX® Delayed Release Capsules, 45 mg and 135 mg
Impax Laboratories Inc. today announced that it is commencing shipment of authorized generic TRILIPIX® (fenofibric acid) delayed release capsules 45 mg and 135 mg...
Press Releases
Tetrahedron announces that Selisseo(R) received a market authorization for use in animal nutrition
Tetrahedron, designing and developing rare natural and synthetic antioxidants for the health nutrition, dermocosmetics and pharmacy sectors, today announces that Selisseo(R) has received marketing...
News
Immune-boosting colorectal cancer drug shows promise
New data on an emerging treatment that aims to fight colorectal cancer by stimulating the immune system have been presented at the ESMO 15th...
News
FDA takes action to protect consumers from dangerous medicines sold by illegal online pharmacies
The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, took action this week against more than 9,600 websites...
Press Releases
Medivir Streamlines Operations by Divesting Cross Pharma, its Parallel Import Business
Medivir AB (STO:MVIR-B) today announced that the company has signed an agreement to sell its wholly owned subsidiary Cross Pharma AB to Unimedic AB...
News
Targeted viral therapy destroys breast cancer stem cells in preclinical experiments
A promising new treatment for breast cancer being developed at Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM)...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read